The death of a patient on the operating table of Jawaharlal Nehru Memorial College and Hospital (JLNMCH) here after being injected with local anaesthesia has triggered a major controversy inside the Assembly and outside as well.
The government has formed a high-level probe committee to probe into the incident, while the JLNMCH management has registered a murder case against the Haridwar-based pharmaceutical company, which manufactures lignocaine, which purportedly caused the patient’s death.
Arvind Kumar Sah (44), a patient from Belhar (Banka), was admitted to JLNMCH with a disease inside his ear. Doctors advised him to undergo surgery. On May 21, Sah was administered lignocaine, an anaesthesia, after which he collapsed on the operation table. The hospital management lodged an FIR with Barari police station in the case.
The incident has rocked the floor of the Assembly with the state government imposing a ban on the use of lignocaine. The move has prompted the hospital management to lodge a case against Embark Life Science Pvt. Ltd, Haridwar, for not fulfilling the criteria of Bihar Medical Services Infrastructure Corporation Ltd (BMSICL) regarding the supply of standard medicines.
Bhagalpur senior superintendent of police Vivek Kumar told reporters that the police would investigate all the contents of the FIR and also interrogate the doctor concerned, the hospital management, the patient’s family members and the Haridwar-based pharmaceutical company’s officers.
Earlier, Sah’s family had also accused the JLNMCH management of trying to suppress the incident. “Though the case was unnatural, the hospital did not conduct an autopsy on the patient and even did not provide us the death certificate. They only handed us a paper for carrying the body for the last rites,” said a family member of Sah.
Two BMSICL members, who visited the hospital, expressed serious concern over the hospital’s role in suppressing facts and not helping the patient’s relatives. BMSICL, which supplies medicines to hospitals in the state, had sent the lignocaine to JLNMCH.
JLNMCH superintendent Ramcharittar Mandal was unavailable on his cellphone.
But sources said the government had assigned the team comprising director of health department, Suresh Prasad, regional deputy director, health, Sudhir Kumar Mahato, and JLNMCH superintendent Ramcharittar Mandal to investigate into the “substandard” drug and the possibility of any negligence by doctor.